Vectura has announced the appointment of Sharon Johnson to the newly created position of Executive VP for Delivery Management “to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space.” Johnson was most recently Senior VP, Global Quality and Regulatory Affairs at Catalent.
In October 2019, Vectura named former Catalent Senior VP, Global Sales and Marketing Will Downie as CEO. Like Downie, Johnson also had previously worked for GE Healthcare; prior to joining Catalent, she served as VP of Quality for GE Healthcare’s Medical Diagnostic Division.
Downie commented, “Sharon has built an enviable reputation as an exceptional leader in the pharmaceutical services space and has a strong track record of transformational leadership, talent development and execution excellence. Our new structure will support growth and sharpen our focus on working with our clients to bring more inhalation medicines to market.”
Johnson said, “Having spent my entire career in the healthcare arena, it is a true privilege to join Vectura, a company with such a rich scientific heritage in the inhalation space. I look forward to working with my colleagues on the executive leadership team and wider business to help combine deep science and agile processes that will accelerate the development of new and exciting inhaled medicines for patients.”
Read the Vectura press release.
